Navigation Links
Wyeth Provides Regulatory Update on Prevnar 13* in the United States
Date:8/11/2009

COLLEGEVILLE, Pa., Aug. 11 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced it received notice that the action date for the U.S. Food and Drug Administration's (FDA) review of the Biologics License Application (BLA) for Prevnar 13(TM), (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) has been extended from September 30, 2009, to December 30, 2009. In response to an FDA request, Wyeth submitted additional analytical method validation and specification information relating to physical/chemical properties of the product in late July. FDA considered this to be a major amendment and, as a result, they have elected to extend the review cycle for Prevnar 13 by 90 days. Prevnar 13 is under review for active immunization of infants and young children for the prevention of invasive disease and otitis media caused by 13 Streptococcus pneumoniae (S. pneumoniae) serotypes.

"This is a significant application that is under priority review and we are working closely with the FDA on the review, including conduct of the pre-approval inspections," says Emilio Emini, Ph.D., executive vice president, Vaccine Research and Development, Wyeth Pharmaceuticals. "Priority review designation is given to products that, if approved, would be a significant therapeutic or public health advance. We continue to believe that our application supports the approval of Prevnar 13."

Prevnar 13(TM) is based on the scientific foundation of Prevnar(R) (Pneumococcal 7-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the standard in pneumococcal disease prevention for infants and young children. It contains the seven serotypes in Prevnar (4, 6B, 9V, 14, 18C, 19F and 23F), plus six additional serotypes (1, 3, 5, 6A, 7F and 19A) respon
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
2. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
3. Wyeth Announces Holder Right to Surrender Convertible Debentures
4. Wyeth Declares Common Stock Dividend
5. New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
6. Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
7. Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
8. Wyeth Declares Common and Preferred Stock Dividends
9. Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
10. Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
11. Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... (PRWEB) August 28, 2014 Whitehouse Laboratories ... long term partnership with PTI Inspection Systems ... with state of the art leak testing method development ... art instruments currently available. As part of this agreement, ... High Voltage Leak Detection Instrument developed and manufactured ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Global Biodegradable Packaging ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html About Biodegradable Packaging ... readily decomposed by the action of microorganisms. ... in terms of raw materials, production technology, ...
(Date:8/27/2014)... Aug. 27, 2014 Research and ... "Global Lactic Acid  (Biodegradable Polymer, Food & Beverage, ... Forecasts to 2019" report to their offering. ... acid with an asymmetrical carbon atom. The main ... polymer, food and beverage, personal care product, and ...
(Date:8/27/2014)... Aug. 27, 2014 Reportbuyer.com has added ... Graphene Opportunity - A Rational View ... New Nanotech? A similar amount of hype ... ranging from microelectronics to water treatment, but is ... availability of the Graphene Opportunity Report, authored by ...
Breaking Biology Technology:Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... stockholders, with part of the proceeds from the $300 million ... shares of PDL on December 1, 2009 will be paid ... a significant amount of convertible securities outstanding, the amount of ...
... ... ... 12, 2009 – Tackling global food security requires an understanding of local situations ... international scale, DuPont Vice President and Pioneer Hi-Bred Chairman Dean Oestreich told a ...
... RIDGE, N.J., Nov. 12 Regado Biosciences, a privately ... active control agents, announced that David Mazzo, PhD, CEO ... Markets 6th Annual Healthcare Conference at the St. Regis ... be given at 1:10pm (EST) on Tuesday, November 17 ...
Cached Biology Technology:PDL BioPharma Announces Special Dividend Payment 2Start Locally, Collaborate to Increase Food Security, Says DuPont Leader to U.N. Group 2Start Locally, Collaborate to Increase Food Security, Says DuPont Leader to U.N. Group 3Start Locally, Collaborate to Increase Food Security, Says DuPont Leader to U.N. Group 4Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009 2
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire-iReach/ -- The IEEE Engineering ... 36 th Annual International Conference (EMBC,14), this year ... in Chicago, Illinois , from Tuesday, ... global leaders, students, and industry professionals in science, medicine, ... - http://photos.prnewswire.com/prnh/20140827/140333 This year,s ...
(Date:8/27/2014)... long-standing belief that a deficiency in serotonin a ... role in depression. In the journal ACS Chemical ... to make serotonin in their brains (and thus should ... depression-like symptoms. , Donald Kuhn and colleagues at ... State University School of Medicine note that depression poses ...
(Date:8/27/2014)... thought to be associated with outcomes after the ... of the patient, mechanism of injury, nerve injured, ... operation technique, and repair materials. However, despite numerous ... nerve injuries, there is no agreement regarding the ... dose-effect relationship of the predictors has not been ...
Breaking Biology News(10 mins):Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3New study throws into question long-held belief about depression 2
... can sail throughout the body via the bloodstream without ... ferry their cargo of anti-cancer drugs and markers into ... In a forthcoming issue of the Germany-based chemistry journal ... UC Santa Barbara and MIT report that their nano-cargo-ship ...
... North Hollywood, CA September 11, 2008 - ... advocacy and support for myeloma patients, families, researchers and ... with multiple myeloma, cancer in the bone marrow that ... edition of the Journal of Clinical Oncology *, ...
... are bracing for Hurricane Ike as it travels over the ... Envisat satellite is tracking the storm, which is forecast to ... Knowing the strength and path of hurricanes is critical for ... of providing synoptic data on the forces that power the ...
Cached Biology News:Researchers develop nano-sized 'cargo ships' to target and destroy tumors 2Researchers develop nano-sized 'cargo ships' to target and destroy tumors 3Researchers develop nano-sized 'cargo ships' to target and destroy tumors 4The IMF says journal editorial documents dramatic increase in survival since the 1980s 2Hurricane Ike tracked by ESA's Envisat 2
...
... Solution, High pH, Concentrated x 10 ... heat-induced target retrievel prior to immunohistochemical staining ... paraffin-embedded tissue sections mounted on glass slides. ... pH, 9.9, is especially effective. It should ...
... solid. Increases the expression of glutathione peroxidase. ... 2 O. Unstable in aqueous solutions; reconstitute ... 3211-76-5, M.W. 196.1. References: Merck Index ... A.F. 1995. Biochem. J. 306, ...
... UN-SCAN-IT gel Software converts any scanner into ... numerous options and features, the basic operation ... JPEG, PCX, BMP, etc.) into pixel density ... steps. Turn your scanner ...
Biology Products: